Skip to content
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
05/26/2023
338211 CEB-01-RLS01 ASCO 21
You might also be interested in
CEBIOTEX receives approval to initiate a paediatric phase II clinical trial for locally resectable abdominal tumours
We are excited to share that the clinical trial to
Read more
La Vanguardia: “Cebiotex, al alza”
Click here to read the online article.
Read more